{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T21:16:52Z","timestamp":1777238212450,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0902288"],"award-info":[{"award-number":["G0902288"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK124408"],"award-info":[{"award-number":["R01 DK124408"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009253","name":"European Association for the Study of the Liver","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["191722\/Z\/13"],"award-info":[{"award-number":["191722\/Z\/13"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015544","name":"King's College Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaut.2025.103436","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T15:36:51Z","timestamp":1746545811000},"page":"103436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives"],"prefix":"10.1016","volume":"154","author":[{"given":"Pengyun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3390-6007","authenticated-orcid":false,"given":"Muhammed","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Gabeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathon","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munther","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Jayne","family":"Blackmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"Hadzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Samyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tassos","family":"Grammatikopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Liberal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Serena","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American Association for the Study of Liver D. Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2025.103436_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jaut.2025.103436_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2011.10.007","article-title":"Autoimmune liver diseases in children - what is different from adulthood?","volume":"25","author":"Mieli-Vergani","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12072-010-9183-5","article-title":"Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management","volume":"4","author":"Oo","year":"2010","journal-title":"Hepatol. Int."},{"issue":"1","key":"10.1016\/j.jaut.2025.103436_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"Longhi","year":"2010","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jaut.2025.103436_bib8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.31893","article-title":"Human leukocyte antigen profile predicts severity of autoimmune liver disease in children of European ancestry","volume":"74","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2025.103436_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1824-7288-36-73","article-title":"HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection","volume":"36","author":"Elfaramawy","year":"2010","journal-title":"Ital. J. Pediatr."},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jceh.2023.01.001","article-title":"Association of HLA DRB1 allele profile with pediatric autoimmune liver disease in India","volume":"13","author":"Maria","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103436_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103436_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2025.103436_bib14","article-title":"Standard immunosuppressive treatment reduces regulatory B cells in children with autoimmune liver disease","volume":"13","author":"Yuksel","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103436_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102619","article-title":"Regulatory T cells in autoimmune hepatitis: an updated overview","volume":"119","author":"Longhi","year":"2021","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.jaut.2025.103436_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MPG.0000000000000245","article-title":"Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives","volume":"58","author":"Wang","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"7","key":"10.1016\/j.jaut.2025.103436_bib18","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2025.103436_bib19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jaut.2025.103436_bib20","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.4049\/jimmunol.181.6.3897","article-title":"The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus","volume":"181","author":"Tsuji-Takayama","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jaut.2025.103436_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA-DRB1\u221703:01 and HLA-DRB1\u221704:01 modify the presentation and outcome in autoimmune hepatitis type-1","volume":"16","author":"van Gerven","year":"2015","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2025.103436_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fimmu.2013.00442","article-title":"The repertoires of peptides presented by MHC-II in the thymus and in peripheral tissue: a clue for autoimmunity?","volume":"4","author":"Collado","year":"2013","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2025.103436_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/jhg.2015.100","article-title":"Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism","volume":"60","author":"Miyadera","year":"2015","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.181.2.677","article-title":"Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II","volume":"181","author":"Sette","year":"1995","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/cei.12843","article-title":"The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model","volume":"186","author":"Yuksel","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103436_bib29","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.27998","article-title":"A novel \u201chumanized mouse\u201d model for autoimmune hepatitis and the association of gut microbiota with liver inflammation","volume":"62","author":"Yuksel","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MPG.0000000000003353","article-title":"Examining the hepatic immune system in children with liver disease with fine needle aspiration","volume":"74","author":"Yuksel","year":"2022","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.jaut.2025.103436_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00365521.2016.1233576","article-title":"Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis","volume":"52","author":"Aarslev","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103436_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000123","article-title":"Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis","volume":"7","author":"Schultheiss","year":"2023","journal-title":"Hepatol. Commun."},{"issue":"4","key":"10.1016\/j.jaut.2025.103436_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2018.05.035","article-title":"Family occurrence of autoimmune hepatitis: a Danish nationwide registry-based cohort study","volume":"69","author":"Gronbaek","year":"2018","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2025.103436_bib35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ajg.2015.50","article-title":"Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011","volume":"110","author":"Moller","year":"2015","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.jaut.2025.103436_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240794","article-title":"Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases","volume":"15","author":"Thomsen","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gronbaek","year":"2014","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2337\/dc18-0288","article-title":"Identical and nonidentical twins: risk and factors involved in development of islet autoimmunity and type 1 diabetes","volume":"42","author":"Triolo","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaut.2025.103436_bib39","article-title":"Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden","volume":"3","author":"Thomsen","year":"2020","journal-title":"J. Transl. Autoimmun."},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib40","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/j.2040-4603.2013.tb00507.x","article-title":"Apoptosis and necrosis in the liver","volume":"3","author":"Guicciardi","year":"2013","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103436_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/08923973.2014.968255","article-title":"Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus","volume":"37","author":"Lavi Arab","year":"2015","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103436_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2025.103436_bib43","first-page":"5153","article-title":"Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis","volume":"8","author":"Lin","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib44","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.31421","article-title":"APECED-associated hepatitis: clinical, biochemical, histological and treatment data from a large, predominantly American cohort","volume":"73","author":"Chascsa","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib45","first-page":"112","article-title":"A novel insight into the pathophysiology of autoimmune hepatitis: an immune activator mutation in the FLT3 receptor","volume":"2","author":"Yuksel","year":"2021","journal-title":"Hepatol. Forum."},{"issue":"3","key":"10.1016\/j.jaut.2025.103436_bib46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc2311867","article-title":"JAK inhibition in STAT1 gain-of-function-mediated treatment-resistant autoimmune hepatitis","volume":"390","author":"Hadzic","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jaut.2025.103436_bib47","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.jhep.2023.09.028","article-title":"Center for Autoimmune Liver Disease Research G. Deleterious variants in TNFAIP3 are associated with type II and seronegative pediatric autoimmune hepatitis","volume":"80","author":"Pandurangi","year":"2024","journal-title":"J. Hepatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:23:45Z","timestamp":1762316625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841125000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S0896841125000812"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103436","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103436"}}